Table 1 Clinical characteristics of men undergoing radical prostatectomy in DVAHCS cohort
From: Prostate cancers with distinct transcriptional programs in Black and White men
Clinical feature | Black | White | P-value |
|---|---|---|---|
Number of patients | 305 | 238 | |
Age at surgery (years) | |||
Mean | 59.9 | 62.7 | < 0.0011 |
Standard deviation | 5.9 | 5.7 | |
PSA prior to surgery (ng/ml) | |||
Median | 7.3 | 7.0 | 0.1061 |
Interquartile range | 5.1, 11.4 | 5, 10.3 | |
Pathological grade group, n (%) | 0.3152 | ||
1 | 30 (10%) | 35 (15%) | |
2 | 194 (63%) | 137 (57%) | |
3 | 48 (16%) | 35 (15%) | |
4 | 14 (5%) | 11 (5%) | |
5 | 18 (6%) | 20 (8%) | |
Pathological stage, n (%) | 0.0032 | ||
T2 | 185 (61%) | 116 (49%) | |
T3 | 92 (30%) | 105 (44%) | |
T4 | 28 (9%) | 17 (7%) | |
Positive surgical margins, n (%) | 0.6142 | ||
No | 47 (15%) | 33 (14%) | |
Yes | 258 (85%) | 205 (86%) | |
Follow-up for men without recurrence (months) | 0.0051 | ||
Median | 103.3 | 121.1 | |
Interquartile Range | 64.9, 156.9 | 75.6, 170.6 | |
Recurrent disease | 0.7332 | ||
No | 148 (49%) | 119 (50%) | |
Yes | 157 (51%) | 119 (50%) | |
PCS subtypes | |||
PCS1 | 5 (2%) | 5 (2%) | 0.6982 |
PCS2 | 170 (56%) | 152 (63%) | 0.0672 |
PCS4 | 131 (43%) | 83 (35%) | 0.0512 |